Skip to main content
Norman Nishioka, MD, Gastroenterology, Boston, MA, Massachusetts General Hospital

NormanShizuakiNishiokaMD

Gastroenterology Boston, MA

Advanced Endoscopic Interventional, Esophagus Disease

Associate Professor of Medicine, Massachusetts General Hospital

Dr. Nishioka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nishioka's full profile

Already have an account?

  • Office

    55 Fruit St
    Gastroenterology Associates Blk 4
    Boston, MA 02114
    Phone+1 617-726-4422
    Fax+1 617-724-6832
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Gastroenterology, 1985 - 1987
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1981 - 1984
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
  • Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
  • Tu1147 LIQUID NITROGEN SPRAY CRYOTHERAPY FOR PALLIATION OF INVASIVE ESOPHAGEAL CARCINOMA: RESULTS FROM A MULTICENTER U.S. REGISTRYMay 2018
  • Tu1147 LIQUID NITROGEN SPRAY CRYOTHERAPY FOR PALLIATION OF INVASIVE ESOPHAGEAL CARCINOMA: RESULTS FROM A MULTICENTER U.S. REGISTRYMay 2018
  • Join now to see all

Press Mentions

  • PENTAX Medical Supports Massachusetts General Hospital with in-Kind Donation to Ugandan Hospital
    PENTAX Medical Supports Massachusetts General Hospital with in-Kind Donation to Ugandan HospitalJanuary 19th, 2016

Grant Support

  • Enhanced Photodynamic Treatment Of Barrett'S EsophagusNational Cancer Institute2001–2002

Hospital Affiliations